InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division — giving investors rare small-cap biotech exposure to high-impact…

U.S.-based companies announced more than 153,000 job cuts in October, the research firm Challenger, Gray & Christmas reported Thursday. “This is the highest total for October in over 20 years,…

Here are some charts that reflect our areas of focus this week at XLU Leads with New High Even though the Utilities SPDR (XLU) cannot keep pace with the Technology…